CN103071015A - Compound Cistanche deserticola tablet - Google Patents

Compound Cistanche deserticola tablet Download PDF

Info

Publication number
CN103071015A
CN103071015A CN2012105316444A CN201210531644A CN103071015A CN 103071015 A CN103071015 A CN 103071015A CN 2012105316444 A CN2012105316444 A CN 2012105316444A CN 201210531644 A CN201210531644 A CN 201210531644A CN 103071015 A CN103071015 A CN 103071015A
Authority
CN
China
Prior art keywords
tablet
prostatic hyperplasia
transformation
yin
obturation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2012105316444A
Other languages
Chinese (zh)
Other versions
CN103071015B (en
Inventor
胡宝山
夏伟荣
陆培群
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Inner Mongolia Lantai Pharmaceutical Co., Ltd.
Original Assignee
SHANGHAI PUDONG GAOXING BIOTECHNOLOGY RESEARCH INSTITUTE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SHANGHAI PUDONG GAOXING BIOTECHNOLOGY RESEARCH INSTITUTE filed Critical SHANGHAI PUDONG GAOXING BIOTECHNOLOGY RESEARCH INSTITUTE
Priority to CN201210531644.4A priority Critical patent/CN103071015B/en
Publication of CN103071015A publication Critical patent/CN103071015A/en
Application granted granted Critical
Publication of CN103071015B publication Critical patent/CN103071015B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a compound Cistanche deserticola tablet. Prostatic hyperplasia is a common disease in elderly men, and is mainly caused by yang acupoint mediation helplessness because of the internal organ deficiency, and no yin transformation and disordered opening and closing because of the kidney deficiency. Symptoms of the prostatic hyperplasia comprise difficult urination, urine discharge failure, penis ache, and urine retention caused by urethra obturation, urine retention in the bladder and underbelly distending pain when the prostatic hyperplasia is severe. The prostatic hyperplasia is treated through turbid yin descending by utilizing qi tonifying, lucidity ascending, qi transformation helping and downward obturation unblocking in the invention. The compound Cistanche deserticola tablet mainly comprises 35% of Cistanche deserticola, 15% of Rhodiola rosea, 10% of Oil Palm Fruit, 7% of root of Urtica dioica L., 5% of Rhizoma Alismatis, 5% of Dioscorea tokoro Makino, 10% of Pygeum Africanum, 2% of Cordyceps sinensis, 2% of lycopene, 2% of Radix Astragali saponin, 5% of Semen Plantaginis, and 2% of total glycoside of ginseng. A case that the prostatic hyperplasia is mainly caused by yang acupoint mediation helplessness because of the internal organ deficiency, and no yin transformation and disordered opening and closing because of the kidney deficiency is considered in the traditional Chinese medicinal science, so the turbid yin descending by utilizing qi tonifying, lucidity ascending, qi transformation helping and downward obturation unblocking is a primary treatment principle in the invention. The above twelve medicines are mixed according to corresponding proportions, undergo ultrafine crushing, and are uniformly stirred to prepare the tablet or a capsule. 1.5-2g of the tablet or the capsule is orally taken each time, and is continuously taken three times a day after each meal by warm water for 6-8 weeks.

Description

Compound recipe Herba Cistanches sheet
One, technical field
The invention belongs to medical technical field, relate to a kind of Chinese medicine compound tablet, refer to more specifically a kind of compound Chinese medicinal preparation of preventing and treating prostatic hyperplasia.
Two, background technology
Prostatic hyperplasia is male's common chronic disease in old age, and commercially available relevant medicine all is difficult to fundamentally prevent and treat prostatic hyperplasia at present, and the present invention adopts traditional Chinese medical science monarch, the mutually auxiliary theoretical control prostatic hyperplasia of negative and positive.
Three, summary of the invention
Prostatic hyperplasia is the old a kind of commonly encountered diseases of male, how to be declined by internal organs void, is difficult invigorating YANG and dredging the orifices, deficiency of kidney-QI, and being difficult of the moon is due to folding is lacked of proper care.This disease shows as dysuria, drowns not draw, and penile pain, the urethra obturation is obstructed when serious, causes the retention of bladder urine, the swollen full distending pain of lower abdomen, the traditional Chinese medical science is called the difficulty in urination.To the treatment of primary disease, still lack at present effective method.The present invention uses the QI invigorating the lucid yang sending up, helps its gasification, lower logical obturation, and the method for the turbid descending the moon is treated this disease, main component of the present invention and proportioning are as follows:
Herba Cistanches: another name Herba Cistanches, the fleshy stem of Orobanchaceae plant; Herba Cistanches contains the number of chemical composition, be mainly phenethyl alcohol glycosides, polysaccharide, iridoids, PEARLITOL 25C, cupreol, hydro carbons, flavonoid, alkaloid, aminoacid and inorganic microelement etc., the kidney invigorating is arranged, the benefit essence, the organs such as male's kidney, testis, penis, spongy body there is great tonification effect, cure mainly kidney yang deficiency, the frequent micturition heeltap.This medicine is monarch drug of the present invention.
Radix Rhodiolae: have another name called Rhodiola sachalinensis, be the Crassulaceae Rhodida plant, Radix Rhodiolae mainly contains phenyl propyl and flavonoid class, its unique activity chemical composition is phenyl propyl, rosavin (activity is the strongest), rosin, rosarin, rhodiolin, rhodioloside and its glycoside unit are namely to butyl alcohol.Rhodosin can promote the synthetic of protein, reduce phosphatase activity, improve superoxide dismutase (SOD) activity and glutathion (GSH) content, suppress the formation of peroxide lipid peroxide (LPO), suppress the formation of cell lipofuscin and active oxygen, the degeneration of inhibitory cell, organ changes, so Radix Rhodiolae is a kind of stronger antioxidant, affect lipid metabolism and resists the free-radical oxidation effect; Strengthen the metabolism of cell with synthetic, improve the vigor of cell.Have QI invigorating, invigorate blood circulation, change the effect of silt, because it has the magical effect of strengthening healthy qi, benefiting qi and nourishing blood, YIN nourishing lung benefiting, the successive dynasties Tibetan medicine is considered as it " lucky three essentials-essence ".
Palm fruit: palm fruit is Serenoa repens Serenoa repens (bartram) small mellow fruit, is rich in various fatty acids and volatile oil, mainly contains oleic acid, lauric acid, myristic acid, Palmic acid, linoleic acid, stearic acid, linolenic acid etc.Sabal, formal name used at school is " sabal ", belongs to the Palmae shrub plant, usually is grown in the area of South and North America's hot climate, but its ripe dry fruit hyoscine.Palm fruit is also referred to as sabal in Europe, and the effect of its extract has: prevention of prostatic hyperplasia: the palm fruit extract can suppress to stimulate the dihydro androgenic gland element secretion of prostate hyperplasia, fundamentally solves the problem of prostatic hyperplasia; Promotion is urinated: it is unblocked that the palm fruit extract can keep prostate normal volume and function thereof to urinate, thereby alleviate the problems such as nocturia, frequent micturition, urgent micturition; Prevention aseptic prostatitis: the palm fruit extract can suppress the activity of Cycloxygenase and lipoxidase, reduces the generation of the inflammatory mediators such as leukotriene, prostaglandin, thereby plays antiinflammatory, edema effect, prevention aseptic prostatitis; Prevent and treat urinary tract infection: the palm fruit extract can promote urinary tract mucosa to produce 1gA, lgG, three kinds of immunoglobulins of lgC, strengthens the resistance of urethra, effectively prevents and treats urinary tract infection.
Palm fruit disturbs the diagnosis of early prostate cancer unlike the medicine of other treatment prostate hyperplasia, also the side effect that causes sexual impotence, alopecia can not arranged as some medicine
The Urtica dioica root: be the root of Urticaceae Urtica plant Urtica dioica, strain Herba Urticae Cannabinae (Urticadioica L.subsp.dioica) is a kind of herbaceos perennial, is extensively studied and uses in developed countries such as America and Europes.As a kind of medical herbs, be used for the treatment of prostatic hyperplasia; Have in addition the effects such as antiviral, enhancing immunity.Its active component mainly contains flavonoid, organic acid, phenols, Phenylpropanoid Glycosides class, sterol, protein, polysaccharide etc.Above three flavor medicines are ministerial drug of the present invention.
Rhizoma Alismatis: belong to Alismataceae; tuber contains and rushes down alcohol (alisol) A; B; C; Alisol A monoacetate (alisol A monoacetate); Alisol B 23-monoacetate (alisol B monoacetate); the single acetic acid vinegar of alisol C (alisol C monoacetate) table alisol (epialisol) A; Rhizoma Alismatis azulene alcohol (alismol); Rhizoma Alismatis azulene alcohol oxide (alismoxide); 16 'beta '-methoxy Alisol B 23-monoacetates (16 β-methocyal-isol B monoacetate); 16 beta-hydroxy Alisol B 23-monoacetates (16 β-hydroxyal-isol B monoacetate), and sitosterol-3-O-stearyl-β-D-glucopyanoside (sitosterol-3-O-steroyl-β-D-glucopyranoside).Also contain choline (cho-line), the elements such as sugar and potassium, calcium, magnesium.Be longer than promoting diuresis to eliminate damp pathogen, expel the heat-evil, be used for dysuria, the edema distension, the puckery pain of stranguria with turbid discharge, seminal emission, foot knee joint flaccidity is soft.
Rhizoma Dioscoreae Septemlobae: Dioscoreaceae, Wild yam; The Rhizoma Dioscoreae Septemlobae rhizome mainly contains dioscin (Dioscin), still contain gracillin (Gracillin), dioscoreassapotoxin A, B (DioscoreasapotoxinA, B) Shan Rhizoma Dioscoreae Septemlobae Saponin (Tokoronin), yononin (Yononin), holder gram ruscogenin-Saponins such as 1-glycoside. dioscorea sapotoxin is the insecticidal constituent in the Rhizoma Dioscoreae Septemlobae of mountain. separating the glycoside unit that obtains from rhizome has: diosgenin (Diosgenin), holder gram ruscogenin (Tokorogenin), Yamogenin (Yamoogenin), yonogenin (Yonogenin), kogagenin (Kogagenin), igagenin (Igagenin) etc. have expelling wind and removing dampness, treating stranguria, diuretic, antiinflammatory, detoxifcation can be treated stranguria with turbid discharge and urinary system infection.
Prunus africana: belong to Rosaceae Li Yake wild arbor trees, the extract of bark and fruit can be restrained the human body fibroblastic growth, and can slow down the epidermal growth factor generation, and prostatosis is had obvious curative effects.Contain in the extract of prunus africana---sterol, terpenoid, can reduce excessive prostaglandin in the patient body, reduce the cholesterol that deposits in the prostate, improve the fragility of vein and blood capillary, also have simultaneously diuresis and anthydropic effect, can greatly improve male prostate and sexual organ disease's genesis.Growth factor receptor inhibitors has the double effects that acts on simultaneously prostate and bladder, can effectively suppress fibroblastic hypertrophy of being caused by basic fibroblast growth factor, thereby can establishment the hypertrophy of fibrous tissue in the prostate, thereby suppress the hypertrophy of prostata tissue.The optimistic wall of urinary bladder fibrosis that suppresses is improved wall of urinary bladder elasticity simultaneously, and bladder function is had protective effect, in addition, also has antiinflammatory and anthydropic activity.
Prunus africana is a kind of traditional prostatitic medical herbs that is used for the treatment of.Contained plant component can diminish inflammation, and alleviates the swelling that prostate occurs because being upset.The situation that can reduce nocturia and urinate and interrupt.Basic fibroblast growth factor (bFGF) is intraprostatic main somatomedin, and bFGF increases the hypertrophy that can cause prostatic cell.The prunus africana extract, the Secondary cases bFGF secretion of energy establishment wall of urinary bladder increases the compensatory that causes and thickens, and the progression of fibrosis of wall of urinary bladder is slowed down, and can reduce the sensitivity of detrusor of bladder, and have antiinflammatory action.Above three flavor medicines are adjuvant drug of the present invention.
Cordycepin: the neplanocin that from Cordyceps militaris (L.) Link., extracts, molecular formula C 10H 13N 5O 3, obvious immunoregulation effect is arranged, antibiotic, antiinflammatory, antivirus action.
Lycopene (lycopene) is the main pigment of mature tomato, is a kind of oxygen-free carotenoid.Hartsen isolated this red crystals first from berry Rhizoma Dioscoreae TamuscommunisL. in 1873.Schunk found the different of this material and carotene in 1913, with its called after lycopene first, used so far.Its molecular formula is C40H56, and molecular weight is 536.85, and sterling is needle-like peony crystal, on molecular structure by 11 conjugated double bonds and 2 straight chain type Hydrocarbon that unconjugated double bond forms.In carotenoid, it has the strongest antioxidant activity.The effect that lycopene is removed free radical outclass other carotenoid and vitamin E, and the speed constant of its singlet-oxygen quenching is 100 times of vitamin E, is one of found powerful antioxidant of occurring in nature up to now.Effect with slow down prostatic hyperplasia and antioxidation, slow down aging.
Radix Astragali saponin: leguminous plant, the extract of the root of the Radix Astragali contains flavones ingredient, calycosin, 3-hydroxy-9,10-dimethoxy pterocarpane, Radix Astragali saponin I, V, III, energy tonifying Qi and lifting yang, benefit is defended consolidating superficial resistance, the balance the body metabolism, and enhancing immunity improves antioxidant ability of organism.
Semen Plantaginis: Plantaginaceae, the seed of Herba Plantaginis, the Herba Plantaginis seed contains a moon aucubin (aucubin), Herba Plantaginis mucopolysaccharide (plantago-mulilage), racemization-plantagoside (plantago-side), all square rafter glycoside acid (geniposidic acid), plantenolic acid (plantenolic acid), succinic acid (succinic acid), adenine (adenine), choline (choline) and 10.43% fatty oil, and cupreol (β-sitosterol), cupreol-3-O-β-D-glucopyanoside (β-sitosteryl-3-O-β-D-glucopyranoside).Clearing away heat and promoting diuresis; Cure mainly: main dysuria, stranguria with turbid discharge leukorrhagia; Car owner's stranguria due to disorder of QI, pain relieving, dredging water passages.Radix Astragali saponin is with Semen Plantaginis two medicine one rise and one drop, and Radix Astragali yang invigorating activating QI is walked bladder to go water under the Semen Plantaginis;
Radix Ginseng total glycosides: Araliaceae, the extract of Radix Ginseng, be rich in 18 kinds of Saponins, can obviously suppress cylinder super-oxidation lipid and form, increase simultaneously the content of Superoxide dismutase and peroxidase, have antioxidation, reduce interior free yl content, be added to the somatic cell vigor, suppress old and feeble, blood sugar lowering.Above five kinds of Chinese medicine is the medicine that makes of the present invention.
The traditional Chinese medical science think prostatic hyperplasia be mainly deficiency of kidney-QI, internal organs void declines, being difficult of the moon is due to the folding imbalance.Therefore the QI invigorating the lucid yang sending up helps its gasification, lower logical obturation, and the turbid descending the moon is the main rule for the treatment of, adopts the prescription of this 12 flavor medical material, meets traditional Chinese medical science monarch, the mutually auxiliary theory of negative and positive.
By the proportioning superfine grinding, uniform stirring is made tablet or capsule above-mentioned 12 herbal medicines.Each oral 1.5-2 gram is swallowed with warm water every day three times after meal, serve on for six to eight weeks.
Four, the specific embodiment
The present invention uses more than 20 routine patients with benign prostate hyperplasias, each oral 1.5-2 gram, every day three times, swallow with warm water after meal, serve on for six to eight weeks, except 2 people not the produce effects, all the other are produce effects all, the phenomenons such as urgent micturition, frequent micturition, pouring drop and urine retention are taken an evident turn for the better, and most patient's nocturia are below 2 times, and what have does not even get up in the night to urinate.Effectively improved quality of life.

Claims (1)

1. the present invention relates to a kind of herbal mixture oral tablet, the one-tenth that it is characterized in that it be grouped into and proportioning as follows:
Figure FSA00000821322200011
By the proportioning superfine grinding, uniform stirring is made tablet or capsule above-mentioned 12 herbal medicines.Each oral 1.5-2 gram is swallowed with warm water every day three times after meal, serve on for six to eight weeks.
CN201210531644.4A 2012-12-11 2012-12-11 Compound Cistanche deserticola tablet Active CN103071015B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201210531644.4A CN103071015B (en) 2012-12-11 2012-12-11 Compound Cistanche deserticola tablet

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201210531644.4A CN103071015B (en) 2012-12-11 2012-12-11 Compound Cistanche deserticola tablet

Publications (2)

Publication Number Publication Date
CN103071015A true CN103071015A (en) 2013-05-01
CN103071015B CN103071015B (en) 2014-09-10

Family

ID=48147860

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201210531644.4A Active CN103071015B (en) 2012-12-11 2012-12-11 Compound Cistanche deserticola tablet

Country Status (1)

Country Link
CN (1) CN103071015B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103599138A (en) * 2013-11-22 2014-02-26 宁波广发文博生物科技有限公司 Cordyceps militaris extract lozenge

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1753682A (en) * 2003-01-16 2006-03-29 利盛私人有限公司 The herbal-composition that is used for prostatosis
CN101732660A (en) * 2009-12-25 2010-06-16 卢速江 Chinese medicinal preparation for treating prostate disease and preparation method thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1753682A (en) * 2003-01-16 2006-03-29 利盛私人有限公司 The herbal-composition that is used for prostatosis
CN101732660A (en) * 2009-12-25 2010-06-16 卢速江 Chinese medicinal preparation for treating prostate disease and preparation method thereof

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
吕海涛: "中药治疗慢性前列腺炎近况", 《湖北中医杂志》 *
曹丹燕等: "红景天口服液对雄性小鼠抗应激作用的研究", 《广东医学》 *
王旨洲等: "前列舒宁丸治疗良性前列腺增生60例", 《现代中医药》 *
程芳等: "植物药治疗良性前列腺增生症的研究进展", 《安徽医药》 *
邱云桥等: "益肾通对前列腺增生症膀胧逼尿肌收缩力影响的临床研究", 《新中医》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103599138A (en) * 2013-11-22 2014-02-26 宁波广发文博生物科技有限公司 Cordyceps militaris extract lozenge
CN103599138B (en) * 2013-11-22 2015-12-09 宁波广发文博生物科技有限公司 Cordyceps militaris (L.) Link. extract lozenge

Also Published As

Publication number Publication date
CN103071015B (en) 2014-09-10

Similar Documents

Publication Publication Date Title
CN102698137A (en) Composition with blood pressure reducing function and preparation method of same
CN106110043A (en) One treats prostatitic Chinese medicine composition and preparation method thereof
CN105213941A (en) A kind of Chinese medicine composition being used for the treatment of infantile diarrhea and preparation method thereof
CN101020015B (en) Externally applied medicine for treating chronic prostatitis and prostatic hyperplasia
CN102886014B (en) Anticancer drug capable of clearing blood and diminishing inflammation
CN104673597A (en) Multifunctional health preserving liquor and production method thereof
CN101601782B (en) Compound tincture for treating dermatophytosis
CN104338031A (en) Leukocyte-increasing traditional Chinese medicine decoction piece combined preparation as well as preparation method and combined package thereof
CN103977372A (en) Traditional Chinese medicine additive used for treating porcine epizootic diarrhea and preparing method thereof
CN103071015B (en) Compound Cistanche deserticola tablet
CN100425266C (en) Medicine for treating cholecystolithiasis and preparation process thereof
CN112717113B (en) Traditional Chinese medicine composition for treating allergic rhinitis and paste formula and application thereof
CN105853628A (en) Traditional Chinese medicine preparation for treating child vaginal hydrocele and preparation method thereof
CN106072560A (en) A kind of for health product treating gout and preparation method thereof
CN105617268A (en) Medicine for treating scale keratinization type beriberi
CN103349108A (en) Warming-yang and tonifying-pleen healthy team cream and preparation method
CN105106781A (en) Traditional Chinese medicine for treating halitosis
CN105796951A (en) External-use preparation used by radiology department for treating nasal polyp and preparation method
CN105434922A (en) Preparation for treating facial paralysis and preparation method thereof
CN105031259A (en) Composition for treating cystitis and preparing method
CN105288166A (en) Traditional Chinese medicine composition for thyroid enlargement and preparation method thereof
CN105288316A (en) Goosegrass herb oral liquid with functions of clearing away heat and removing dampness and protecting liver and benefiting gallbladder and preparation method thereof
CN105031403A (en) Tea drink capable of eliminating faeces and enterotoxin and preparation method thereof
CN115177700A (en) Multifunctional bath preparation and preparation method and application thereof
CN104147157B (en) A kind of Chinese patent medicine treating old man's prostatic hyperplasia

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C41 Transfer of patent application or patent right or utility model
TR01 Transfer of patent right

Effective date of registration: 20160308

Address after: 010080 the Inner Mongolia Autonomous Region Hohhot Jinchuan Development Zone, Jin Er Lu

Patentee after: Inner Mongolia Lantai Pharmaceutical Co., Ltd.

Address before: 201200 Shanghai city Pudong New Area Chuansha 54 paper Stone Road Lane 4, Room 502

Patentee before: Shanghai Pudong Gaoxing Biotechnology Research Institute